WallStreetZenWallStreetZen

NYSE: TAK
Takeda Pharmaceutical Co Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Takeda Pharmaceutical Co revenue was $29.99B for the trailing 12 months ending Jun 30, 2025, with -0.3% growth year over year. Quarterly revenue for the quarter (Q2 2025) ending on Jun 30, 2025 was $7.6B, up 8.3% from last quarter. For the last reported fiscal year 2025 ending Mar 31, 2025, TAK annual revenue was $30.7B, with 9% growth year-over-year.

TAK past revenue growth

How has TAK's revenue growth performed historically?

Company
10.64%
Industry
10.78%
Market
37.92%
TAK's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
TAK's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
TAK's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

TAK revenue history

Current Revenue
$30.9B
Current Earnings
$945.5M
Current Profit Margin
3.1%

Be the first to know when TAK announces revenue.

TAK Revenue History By Year

TAK Yearly RevenueTAK RevenueTAK ChangeTAK Revenue Growth
2025-03-31$30.69B$2.52B+8.96%
2024-03-31$28.16B-$2.26B-7.42%
2023-03-31$30.42B$1.14B+3.90%
2022-03-31$29.28B-$86.52M-0.29%
2021-03-31$29.36B-$1.14B-3.73%
2020-03-31$30.50B$11.44B+59.98%
2019-03-31$19.07B$3.58B+23.08%
2018-03-31$15.49B-$142.02M-0.91%
2017-03-31$15.63BN/AN/A

1 of 1

Takeda Pharmaceutical Co Revenue FAQ

What was TAK's revenue last quarter?

On Invalid Date, Takeda Pharmaceutical Co (NYSE: TAK) reported Q2 2025 revenue of $7.64 billion up 0.16% year over year. In the same quarter last year, Takeda Pharmaceutical Co's revenue was $7.66 billion.

What was Takeda Pharmaceutical Co's revenue in 2025?

Takeda Pharmaceutical Co's annual revenue for the twelve months ending Mar 31, 2025 was $30.69 billion, a 8.96% increase year over year.

How much does Takeda Pharmaceutical Co make in a day?

Based on Takeda Pharmaceutical Co annual revenue for the past five years, TAK makes an average of $81,047,090.54 per day.

What was Takeda Pharmaceutical Co's annual revenue growth in the past year?

As of Q3 2025, Takeda Pharmaceutical Co's revenue has grown 10.64% year over year. This is 0.15 percentage points lower than the US Drug Manufacturers - Specialty & Generic industry revenue growth rate of 10.78%. Takeda Pharmaceutical Co's revenue in the past year totaled $29.99 billion.

How much does Takeda Pharmaceutical Co make in a year?

Takeda Pharmaceutical Co's revenue by year for the past five years is:
  • Takeda Pharmaceutical Co's revenue for the twelve months ending Mar 31, 2025 was $30.69 billion, a 8.96% increase year over year.
  • Takeda Pharmaceutical Co's annual revenue for Mar 31, 2024 was $28.16 billion, a 7.42% decrease from 2023.
  • Takeda Pharmaceutical Co's annual revenue for 2023 was $30.42 billion, a 3.9% increase from 2022.
  • Takeda Pharmaceutical Co's annual revenue for 2022 was $29.28 billion, a 0.29% decrease from 2021.
  • Takeda Pharmaceutical Co's annual revenue for 2021 was $29.36 billion, a 3.73% decrease from 2020.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.